Hakin-1
Hakin-1 is a E3 Ubiquitin-Ligase Hakai inhibitor. Hakin-1 blocks Hakai-mediated global ubiquitination and specific ubiquitination of E-cadherin and inhibits epithelial-mesenchymal transition (EMT) progression. Hakan-1 inhibits tumor progression and cancer metastasis. Hakin-1 can be used for the study of carcinoma such as colorectal cancer[1].
Product Specifications
CAS Number
[346660-34-2]
UNSPSC
12352005
Target
Cadherin; E1/E2/E3 Enzyme
Related Pathways
Cytoskeleton; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(C1=CC=C(N2N=NN=C2SCC(C3=CC=C([N+]([O-])=O)C=C3)=O)C=C1)O
Molecular Formula
C16H11N5O5S
Molecular Weight
385.35
References & Citations
[1]Martinez-Iglesias O, et al. Hakin-1, a New Specific Small-Molecule Inhibitor for the E3 Ubiquitin-Ligase Hakai, Inhibits Carcinoma Growth and Progression. Cancers (Basel) . 2020 May 23;12 (5) :1340.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![NMDA Receptor NR2B, phosphorylated (Tyr1336) (NMDA R2b, NMDAR2B, N-methyl-D-aspartate, GRIN2B, Glutamate [NMDA] Receptor Subunit epsilon-2, NR2B, N-methyl-D-aspartate Receptor Subunit 2B) (MaxLight 650) discontinued](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
N2904-35J-ML650 100 µL
NMDA Receptor NR2B, phosphorylated (Tyr1336) (NMDA R2b, NMDAR2B, N-methyl-D-aspartate, GRIN2B, Glutamate [NMDA] Receptor Subunit epsilon-2, NR2B, N-methyl-D-aspartate Receptor Subunit 2B) (MaxLight 650) discontinued
Ask
View Details NB100-64398FR 0.1 mL
Mouse Monoclonal Cytomegalovirus Antibody (HCMV16 (51C1)) [DyLight 680]
Ask
View Details U4100-63B-Biotin 200 µL
USP16, ID (Ubiquitin Thiolesterase 16, Ubiquitin-specific Processing Protease 16, Deubiquitinating Enzyme 16, Ubiquitin Processing Protease UBP-M, MSTP039) (Biotin) discontinued
Ask
View Details 